Regional differences in self-reported screening, prevalence and management of cardiovascular risk factors in Switzerland

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Marques Vidal, Pedro ^a   Paccaud, Fred ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Diabetes; Dyslipidemia; Geographical differences; Hypertension; Obesity; Smoking; Switzerland

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIABETES MELLITUS; DYSLIPIDEMIA; EDUCATIONAL STATUS; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; MALE; MARRIAGE; MASS SCREENING; MIDDLE AGED; MIGRATION; MULTIVARIATE ANALYSIS; OBESITY; PREVALENCE; PSYCHOLOGICAL ASPECT; RISK FACTOR; SELF REPORT; SMOKING; SOCIAL CLASS; STATISTICS; SWITZERLAND; UTILIZATION REVIEW;

ADULT; AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DYSLIPIDEMIAS; EDUCATIONAL STATUS; FEMALE; HUMANS; HYPERTENSION; MALE; MARITAL STATUS; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; POPULATION SURVEILLANCE; PREVALENCE; RESIDENCE CHARACTERISTICS; RISK FACTORS; SELF REPORT; SMOKING; SOCIAL CLASS; SWITZERLAND; TRANSIENTS AND MIGRANTS;

EID: 84858977194     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-246     Document Type: Article

References (36)

1. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Levi F, Lucchini F, Negri E, La Vecchia C, Heart 2002 88 119 124 10.1136/heart.88.2.119 12117828 (Pubitemid 34787755)
2. Geographic variation in cardiovascular disease mortality in US blacks and whites. Pickle LW, Gillum RF, J Natl Med Assoc 1999 91 545 556 10599187
3. Geographic variance of cardiovascular risk factors among community women: the national Sister to Sister campaign. Jarvie JL, Johnson CE, Wang Y, Aslam F, Athanasopoulos LV, Pollin I, et al. J Womens Health (Larchmt) 2011 20 11 19 10.1089/jwh.2010.2036
4. Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study. Lawlor DA, Bedford C, Taylor M, Ebrahim S, J Epidemiol Community Health 2003 57 134 140 10.1136/jech.57.2.134 12540690 (Pubitemid 36160623)
5. Geographical differences in blood pressure of male youth aged 17-21 years in China. Lei S, Yong-Yong X, Xiao-Han D, Chang-Sheng C, Blood Press 2004 13 169 175 10.1080/08037050410035545 15223726 (Pubitemid 38967761)
6. Regional variation in self-reported heart disease prevalence in Canada. Chow CM, Donovan L, Manuel D, Johansen H, Tu JV, Can J Cardiol 2005 21 1265 1271 16341294 (Pubitemid 43174606)
7. Variations in cardiovascular disease under-diagnosis in England: national cross-sectional spatial analysis. Soljak M, Samarasundera E, Indulkar T, Walford H, Majeed A, BMC Cardiovasc Disord 2011 11 12 10.1186/1471-2261-11-12 21414221
8. Awareness, treatment and control of hyperlipidaemia in middle-aged men in France and Northern Ireland in 1991-1993: the PRIME study. Prospective epidemiological study of myocardial infarction. Marques-Vidal P, Arveiler D, Evans A, Amouyel P, Ferrières J, Luc G, et al. Acta Cardiol 2002 57 117 123 10.2143/AC.57.2.2005383 12003258 (Pubitemid 34296889)
9. East-west differences in reported preventive practices. A comparative study of six European areas of the WHO-CINDI programme. Pardell H, Roure E, Drygas W, Morava E, Nussel E, Puska P, et al. Eur J Public Health 2001 11 393 396 10.1093/eurpub/11.4.393 11766479 (Pubitemid 33126480)
10. Why mortality from heart disease is low in France. High cholesterol may not have same effect on cardiovascular risk in southern Europe as elsewhere. Marrugat J, Senti M, BMJ 2000 320 250 10.1136/bmj.320.7229.250 10712023
11. Exploring the disparities of regional health care expenditures in Switzerland: some empirical evidence. Reich O, Weins C, Schusterschitz C, Thoni M, Eur J Health Econ 2011
12. Etat de la prévention du tabagisme dans les cantons [Status of smoking prevention among cantons]. Office Fédéral de la Santé Publique [Federal Office of Public Health] 2011 22470315
13. Using spatial analysis to demonstrate the heterogeneity of the cardiovascular drug-prescribing pattern in Taiwan. Cheng CL, Chen YC, Liu TM, Yang YH, BMC Publ Health 2011 11 380 10.1186/1471-2458-11-380
14. Regional differences of glycaemic control in patients with type 2 diabetes mellitus in Switzerland: a national cross-sectional survey. Gerber PA, Spirk D, Brandle M, Thoenes M, Lehmann R, Keller U, Swiss Med Wkly 2011 141 13218 21735364
15. Schweizerische Gesundheitsbefragung, Gesundheit und Gesundheitsverhalten in der Schweiz 1997 [Swiss Health Survey: Health behavior and health in Switzerland 1997] Neuchtel, Swtzerland: Bundesamt für Statistik [Federal Office of Statistics] 2000
16. IHA-GfK, Schweizerische Gesundheitsbefragung SGB 2002 - Schlussbericht zur Datenerhebung [Swiss Health Survey 2002 - Final Report on Data Collection] Neuchtel, Switzerland: Bundesamt für Statistik [Federal Office of Statistics] 2003
17. Excess weight in the canton of Zurich, 1992-2009: harbinger of a trend reversal in Switzerland? Faeh D, Bopp M, Swiss Med Wkly 2010 140 13090 20809434
18. Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study. Danon-Hersch N, Marques-Vidal P, Bovet P, Chiolero A, Paccaud F, Pécoud A, et al. Eur J Cardiovasc Prev Rehabil 2009 16 66 72 10.1097/HJR.0b013e32831e9511 19188810
19. Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England. Ward PR, Noyce PR, Leger St AS, J Epidemiol Community Health 2004 58 89 96 10.1136/jech.58.2.89 14729882 (Pubitemid 38130474)
20. Prevalence, treatment and control of dyslipidaemia in Switzerland: still a long way to go. Firmann M, Marques-Vidal P, Paccaud F, Mooser V, Rodondi N, Waeber G, et al. Eur J Cardiovasc Prev Rehabil 2010 17 682 687 10.1097/HJR.0b013e32833a09ab 20700055
21. Prescription de statines en prevention primaire: quel score de risque cardiovasculaire faut-il utiliser en Suisse? [Statin prescription in primary prevention: which cardiovascular risk score should be used in Switzerland?]. Nanchen D, Chiolero A, Marques-Vidal PM, Cornuz J, Waeber G, Vollenweider P, et al. Rev Med Suisse 2010 6 488 493 20373694
22. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Reiner Z, Catapano AL, De BG, Graham I, Taskinen MR, Wiklund O, et al. Eur Heart J 2011 32 1769 1818 21712404
23. Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland. Marques-Vidal P, Rodondi N, Bochud M, Pécoud A, Hayoz D, Paccaud F, et al. Eur J Cardiovasc Prev Rehabil 2008 15 402 408 10.1097/HJR.0b013e3282fb040f 18677163
24. Statins for cardiovascular prevention according to different strategies: a cost analysis. Ito MK, Nanchen D, Rodondi N, Paccaud F, Waeber G, Vollenweider P, et al. Am J Cardiovasc Drugs 2011 11 33 44 10.2165/11586760-000000000-00000 21265581
25. Prevalence, awareness and treatment of type 2 diabetes mellitus in Switzerland: the CoLaus study. Kaiser A, Vollenweider P, Waeber G, Marques-Vidal P, Diabet Med 2012 29 2 190 7 21883431
26. Screening for type 2 diabetes. American Diabetes Association, Diabetes Care 2004 27 Suppl 1 11 S14 14693922
27. Diagnosis and classification of diabetes mellitus. American Diabetes Association, Diabetes Care 2008 31 Suppl 1 55 S60 18165338
28. Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Dyson PA, Kelly T, Deakin T, Duncan A, Frost G, Harrison Z, et al. Diabet Med 2011 28 1282 1288 10.1111/j.1464-5491.2011.03371.x 21699560
29. WHO/NMH/MNC/03. World Health Organization, Screening for type 2 diabetes Geneva, Switzerland: World Health Organization, Department of Noncommunicable Disease Management, 2003 1 54
30. OECD, WHO, OECD Reviews of Health Systems: Switzerland 2011 Paris, France: OECD Publishing 2011
31. Predictive accuracy of original and recalibrated Framingham risk score in the Swiss population. Marques-Vidal P, Rodondi N, Bochud M, Chiolero A, Pecoud A, Hayoz D, et al. Int J Cardiol 2009 133 346 353 10.1016/j.ijcard.2008.01.004 18485502
32. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. Kotseva K, Wood D, De Backer G, de Bacquer D, Pyörälä K, Reiner Z, et al. Eur J Cardiovasc Prev Rehabil 2010 17 530 540 10.1097/HJR.0b013e3283383f30 20577089
33. Obesity in Switzerland: do estimates depend on how body mass index has been assessed? Faeh D, Marques-Vidal P, Chiolero A, Bopp M, Swiss Med Wkly 2008 138 204 210 18389393 (Pubitemid 351533229)
34. Tolonen H, Koponen P, Aromaa A, Conti S, Graff-Iversen S, Grøtvedt L, et al. Recommendations for organizing a standardized European Health Examination Survey. 22/2008, 1-13 Helsinki, Finland: Kansanterveyslaitos (KTL) [National Public Health Institute] 2008
35. Tolonen H, Koponen P, Aromaa A, Conti S, Graff-Iversen S, Grøtvedt L, et al. Recommendations for the Health Examination Surveys in Europe. 21/2008, 1-181 Helsinki, Finland: Kansanterveyslaitos (KTL) [National Public Health Institute] 2008
36. Tolonen H, Koponen P, Aromaa A, Conti S, Graff-Iversen S, Grøtvedt L, et al. Review of Health Examination Surveys in Europe. 18/2008 Helsinki, Finland: Kansanterveyslaitos (KTL) [National Public Health Institute] 2008